Department of Radiology, Catharina Hospital Eindhoven, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands.
Department of Internal Medicine, Division of Medical Oncology, GROW, Maastricht University Medical Centre, P Debyelaan 1, 6229 HA, Maastricht, The Netherlands.
Br J Cancer. 2020 Jul;123(2):325-332. doi: 10.1038/s41416-020-0870-2. Epub 2020 May 11.
Delay in detection of breast cancer may worsen tumour characteristics, with progression of tumour size and a higher risk of metastatic lymph nodes. The purpose of this study was to investigate delayed breast cancer diagnosis after repeated recall for the same mammographic abnormality at screening.
This was a retrospective study performed in two cohorts of women enrolled in a mammography screening programme in the Netherlands. All women aged 50-75 who underwent biennial screening mammography either between January 1, 1997 and December 31, 2006 (cohort 1) or between January 1, 2007 and December 31, 2016 (cohort 2) were included.
The cohorts showed no difference in proportions of women with delayed breast cancer diagnosis of at least 2 years (2.2% versus 2.8%, P = 0.29). Most delays were caused by incorrect BI-RADS classifications after recall (74.2%). An increase in mean tumour size was seen when comparing sizes at initial false-negative recall and at diagnosis of breast cancer (P < 0.001).
The proportion of women with a long delay in breast cancer confirmation following repeated recall at screening mammography has not decreased during 20 years of screening. These delays lead to larger tumour size at detection and may negatively influence prognosis.
乳腺癌的检测延迟可能会导致肿瘤特征恶化,肿瘤大小进展,转移淋巴结的风险增加。本研究旨在调查在筛查时对同一乳房 X 线摄影异常进行重复召回后乳腺癌诊断的延迟情况。
这是在荷兰进行的两项乳房 X 线摄影筛查计划中的女性队列的回顾性研究。所有年龄在 50-75 岁之间的女性,在 1997 年 1 月 1 日至 2006 年 12 月 31 日(队列 1)或 2007 年 1 月 1 日至 2016 年 12 月 31 日(队列 2)期间每两年接受一次筛查乳房 X 线摄影。
两个队列在至少 2 年的乳腺癌诊断延迟比例(2.2%与 2.8%,P=0.29)上没有差异。大多数延迟是由于召回后 BI-RADS 分类错误(74.2%)引起的。比较初始假阴性召回和乳腺癌诊断时的肿瘤大小,发现平均肿瘤大小有所增加(P<0.001)。
在 20 年的筛查中,在筛查乳房 X 线摄影时对同一乳房 X 线摄影异常进行重复召回后,乳腺癌确诊的女性中长延迟的比例并未降低。这些延迟导致检测时肿瘤更大,可能会对预后产生负面影响。